| Primary |
| Product Used For Unknown Indication |
56.1% |
| Epilepsy |
21.8% |
| Drug Use For Unknown Indication |
7.7% |
| Maternal Exposure Timing Unspecified |
2.0% |
| Accidental Exposure To Product |
1.4% |
| Depression |
1.2% |
| Bipolar Disorder |
1.0% |
| Bipolar I Disorder |
1.0% |
| Convulsion |
0.9% |
| Hypertension |
0.9% |
| Intentional Overdose |
0.9% |
| Petit Mal Epilepsy |
0.9% |
| Anaesthesia |
0.7% |
| Partial Seizures |
0.7% |
| Psychotic Disorder |
0.7% |
| Drug Exposure During Pregnancy |
0.5% |
| Major Depression |
0.5% |
| Pain |
0.5% |
| Urinary Tract Infection |
0.5% |
| Device Related Infection |
0.3% |
|
| Product Counterfeit |
15.6% |
| Trismus |
13.0% |
| Tremor |
9.1% |
| Petit Mal Epilepsy |
5.2% |
| Thrombocytopenia |
5.2% |
| Toxicity To Various Agents |
5.2% |
| Drug Interaction |
3.9% |
| Renal Failure Acute |
3.9% |
| Somnolence |
3.9% |
| Sopor |
3.9% |
| Speech Disorder |
3.9% |
| Vocal Cord Disorder |
3.9% |
| Vomiting |
3.9% |
| Weight Increased |
3.9% |
| Foetal Exposure During Pregnancy |
2.6% |
| Hyponatraemia |
2.6% |
| Intentional Overdose |
2.6% |
| Medication Residue |
2.6% |
| Muscle Twitching |
2.6% |
| Oedema Peripheral |
2.6% |
|
| Secondary |
| Product Used For Unknown Indication |
29.7% |
| Epilepsy |
29.5% |
| Drug Use For Unknown Indication |
9.4% |
| Schizophrenia |
4.2% |
| Psychotic Disorder |
4.0% |
| Convulsion |
2.8% |
| Anxiolytic Therapy |
2.4% |
| Intentional Overdose |
2.2% |
| Type 2 Diabetes Mellitus |
2.0% |
| Affective Disorder |
1.8% |
| Bipolar I Disorder |
1.8% |
| Depression |
1.8% |
| Oligodendroglioma |
1.4% |
| Sedative Therapy |
1.4% |
| Antidepressant Therapy |
1.2% |
| Conversion Disorder |
1.0% |
| Bacteraemia |
0.8% |
| Bipolar Disorder |
0.8% |
| Mental Disorder |
0.8% |
| Partial Seizures |
0.8% |
|
| Trismus |
9.1% |
| Weight Increased |
9.1% |
| Product Counterfeit |
8.0% |
| Rash Maculo-papular |
6.8% |
| Thrombocytopenia |
6.8% |
| Medication Residue |
5.7% |
| Posture Abnormal |
5.7% |
| Vomiting |
5.7% |
| Pancytopenia |
4.5% |
| Posterior Reversible Encephalopathy Syndrome |
4.5% |
| Psychomotor Skills Impaired |
4.5% |
| Hyponatraemia |
3.4% |
| Inappropriate Antidiuretic Hormone Secretion |
3.4% |
| Neutropenia |
3.4% |
| Pneumonia |
3.4% |
| Status Epilepticus |
3.4% |
| Suicide Attempt |
3.4% |
| Syncope |
3.4% |
| Tremor |
3.4% |
| Ankle Fracture |
2.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
19.4% |
| Epilepsy |
13.9% |
| Product Used For Unknown Indication |
12.1% |
| Bipolar Disorder |
9.5% |
| Depression |
5.2% |
| Schizophrenia |
4.6% |
| Suicide Attempt |
4.6% |
| Insomnia |
3.8% |
| Rheumatoid Arthritis |
3.2% |
| Anxiety |
2.9% |
| Psychotic Disorder |
2.9% |
| Bipolar I Disorder |
2.6% |
| Hypertension |
2.6% |
| Post-traumatic Stress Disorder |
2.3% |
| Prophylaxis |
2.3% |
| Pain |
2.0% |
| Atrial Fibrillation |
1.7% |
| Idiopathic Generalised Epilepsy |
1.7% |
| Simple Partial Seizures |
1.4% |
| Back Pain |
1.2% |
|
| Thrombocytopenia |
7.8% |
| Toxicity To Various Agents |
7.8% |
| Somnolence |
6.3% |
| Status Epilepticus |
6.3% |
| Syncope |
6.3% |
| Tibia Fracture |
6.3% |
| Tremor |
6.3% |
| Vomiting |
6.3% |
| Weight Increased |
6.3% |
| Grand Mal Convulsion |
4.7% |
| Product Measured Potency Issue |
4.7% |
| Renal Failure Acute |
4.7% |
| Rhabdomyolysis |
4.7% |
| Depressive Symptom |
3.1% |
| Diplopia |
3.1% |
| Malignant Melanoma |
3.1% |
| Overdose |
3.1% |
| Pneumonia Aspiration |
3.1% |
| Tension |
3.1% |
| Tonic Clonic Movements |
3.1% |
|
| Interacting |
| Epilepsy |
38.5% |
| Alopecia |
15.4% |
| Drug Use For Unknown Indication |
15.4% |
| Pericardial Effusion |
15.4% |
| Pulmonary Tuberculosis |
15.4% |
|
| Drug Level Increased |
25.0% |
| Nervous System Disorder |
25.0% |
| Somnolence |
25.0% |
| Drug Interaction |
12.5% |
| Epilepsy |
12.5% |
|
